Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00901771 · ClinicalTrials.gov registry record · NA
Study of Provent Treatment of Obstructive Sleep Apnea in Patients Who Are Non-compliant With CPAP
A NA study, sponsored by St. Luke's Hospital, Chesterfield, Missouri.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00901771 is a NA study that has completed, run by St. Luke's Hospital, Chesterfield, Missouri. The registered enrollment target is 50 participants.
The verdict
NCT00901771, a NA study, has completed, sponsored by St. Luke's Hospital, Chesterfield, Missouri.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The primary objective of the proposed investigation is to evaluate the efficacy of the Provent device in a sample of OSA patients who have either refused or been non-adherent with PAP treatment. Both initial efficacy (evaluated after approximately one week with Provent) and efficacy after approximately 5 weeks in patients who demonstrate initial efficacy will be assessed. A secondary objective is to assess adherence with Provent treatment during the 5-week evaluation period.
Interventions
- DEVICE Provent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-05 |
| Est. Completion | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00901771
The ClinicalTrials.gov registry entry for NCT00901771 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Luke's Hospital, Chesterfield, Missouri, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Provent is the first listed.
NCT00901771 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00901771 about?
NCT00901771 is a clinical study titled "Study of Provent Treatment of Obstructive Sleep Apnea in Patients Who Are Non-compliant With CPAP". The primary objective of the proposed investigation is to evaluate the efficacy of the Provent device in a sample of OSA patients who have either refused or been non-adherent with PAP treatment. Both initial efficacy (evaluated after approximately one week with Provent) and efficacy after approximat...
What is the current status of trial NCT00901771?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2009-05. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00901771?
The interventions under investigation include: Provent (DEVICE).
Who is sponsoring clinical trial NCT00901771?
This trial is sponsored by St. Luke's Hospital, Chesterfield, Missouri, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.